Role for standards in assays of botulinum toxins: international collaborative study of three preparations of botulinum type A toxin

被引:67
作者
Sesardic, D
Leung, T
Das, RG
机构
[1] Natl Inst Biol Stand & Controls, Div Bacteriol, Potters Bar EN6 3QG, Herts, England
[2] Natl Inst Biol Stand & Controls, Informat Lab, Potters Bar EN6 3QG, Herts, England
关键词
botulinum A toxin; standardization; collaborative study;
D O I
10.1016/j.biologicals.2003.08.001
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The biological activity of therapeutic preparations of botulinum type A toxin is currently expressed in units defined on the basis of the median lethal intraperitoneal dose of that preparation in mice at 72 h, the LD50 dose. In this study we describe the comparison, by ten laboratories in five countries, of three different formulations of botulinum type A toxin using the mouse lethality test, and also using the relative activities of the preparations. The results of this study show that use of a standard preparation and expression of relative potency gives substantially greater consistency between and within laboratories than when mouse LD50 unit is used to define activity of botulinum toxin. (C) 2003 The International Association for Biologicals. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:265 / 276
页数:12
相关论文
共 33 条
[1]   A comparison of the safety margins of botulinum neurotoxin serotypes A, B, and F in mice [J].
Aoki, KR .
TOXICON, 2001, 39 (12) :1815-1820
[2]   THERAPEUTIC BOTULINUM TOXIN [J].
BORODIC, G .
LANCET, 1994, 344 (8933) :1370-1370
[3]   Botulinum toxin therapy, immunologic resistance, and problems with available materials [J].
Borodic, G ;
Johnson, E ;
Goodnough, M ;
Schantz, E .
NEUROLOGY, 1996, 46 (01) :26-29
[4]  
Brin M F, 1991, Arch Neurobiol (Madr), V54, P173
[5]  
BRIN MF, 1993, J ROY SOC MED, V86, P494
[6]   Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia [J].
Brin, MF ;
Lew, MF ;
Adler, CH ;
Comella, CL ;
Factor, SA ;
Jankovic, J ;
O'Brien, C ;
Murray, JJ ;
Wallace, JD ;
Willmer-Hulme, A ;
Koller, M .
NEUROLOGY, 1999, 53 (07) :1431-1438
[7]  
BURN JH, 1950, BIOL STANDARDIZATION
[8]  
DASGAINES RE, 1999, DEV BIOL STAND, V101, P267
[9]   Recombinant SNAP-25 is an effective substrate for Clostridium botulinum type A toxin endopeptidase activity in vitro [J].
Ekong, TAN ;
Feavers, IM ;
Sesardic, D .
MICROBIOLOGY-SGM, 1997, 143 :3337-3347
[10]   IMMUNOLOGICAL DETECTION OF CLOSTRIDIUM-BOTULINUM TOXIN TYPE-A IN THERAPEUTIC PREPARATIONS [J].
EKONG, TAN ;
MCLELLAN, K ;
SESARDIC, D .
JOURNAL OF IMMUNOLOGICAL METHODS, 1995, 180 (02) :181-191